Linden Lake Venture Capital aims to found, build and invest in the next-generation of biotechnology companies bringing transformative new molecular medicines to patients in need. Our approach is hands-on and our focus is on early-stage (pre-clinical/phase I) technologies.
We focus on leveraging the body’s own molecular biology and potentiate its innate ability to heal and regenerate itself
Linden Lake’s team has a unique skill set that combines technology area and medical expertise, legal acumen, and private equity investment experience; as well as a long and consistent track record of entrepreneurial success.